This content is from:xinyabo体育
Hedge Funds Get a Boost from Microsoft, Google
Firms invested in the tech stalwarts, including ValueAct and Lone Pine, have earned gains from these stocks that have helped ease losses from Valeant Pharmaceuticals.
O. Andreas Halvorsen, Viking Global Investors (Bloomberg) The past few weeks have not been easy for hedge funds, but many of them have tech stocks to thank for keeping the damage under control. While several hedge funds have been hurt recently by the collapse in their huge stakes in Valeant Pharmaceuticals International,
To continue reading,subscribe nowto Premium Journalism. Already a subscriber?Login.